{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:30:01Z","timestamp":1793320201440,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM106392"],"award-info":[{"award-number":["P30GM106392"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM114732"],"award-info":[{"award-number":["P30GM114732"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL072889"],"award-info":[{"award-number":["HL072889"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vascular Vision Pharmaceuticals Co."},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL072889"],"award-info":[{"award-number":["HL072889"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1621-5","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T12:56:21Z","timestamp":1535806581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4\/signal transducer and activator of transcription 6\/Janus kinase 1 pathway"],"prefix":"10.1186","volume":"16","author":[{"given":"Mohamed A.","family":"Ghonim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome V.","family":"Ibba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh H.","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusma","family":"Pyakurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyes","family":"Benslimane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaker","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9916-8126","authenticated-orcid":false,"given":"A. Hamid","family":"Boulares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"1621_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","volume":"391","author":"A Papi","year":"2017","unstructured":"Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2017;391:783\u2013800.","journal-title":"Lancet"},{"key":"1621_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jaci.2015.05.052","volume":"136","author":"PJ Barnes","year":"2015","unstructured":"Barnes PJ. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. J Allergy Clin Immunol. 2015;136:531\u201345.","journal-title":"J Allergy Clin Immunol"},{"key":"1621_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1042\/CS20160487","volume":"131","author":"PJ Barnes","year":"2017","unstructured":"Barnes PJ. Cellular and molecular mechanisms of asthma and COPD. Clin Sci (Lond). 2017;131:1541\u201358.","journal-title":"Clin Sci (Lond)"},{"key":"1621_CR4","first-page":"507151","volume":"2015","author":"S Mousavi","year":"2015","unstructured":"Mousavi S, Moradi M, Khorshidahmad T, Motamedi M. Anti-inflammatory effects of heparin and its derivatives: a systematic review. Adv Pharmacol Sci. 2015;2015:507151.","journal-title":"Adv Pharmacol Sci"},{"key":"1621_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/ph9030038","volume":"9","author":"EI Oduah","year":"2016","unstructured":"Oduah EI, Linhardt RJ, Sharfstein ST. Heparin: past, present, and future. Pharmaceuticals (Basel). 2016;9:38.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1621_CR6","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2217\/nnm-2017-0127","volume":"12","author":"CR Alaez-Verson","year":"2017","unstructured":"Alaez-Verson CR, Lantero E, Fernandez-Busquets X. Heparin: new life for an old drug. Nanomedicine (Lond). 2017;12:1727\u201344.","journal-title":"Nanomedicine (Lond)"},{"key":"1621_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/ajrccm.160.2.9812076","volume":"160","author":"T Ahmed","year":"1999","unstructured":"Ahmed T, Gonzalez BJ, Danta I. Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin. Am J Respir Crit Care Med. 1999;160:576\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"1621_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/039463201302600208","volume":"26","author":"LS Fu","year":"2013","unstructured":"Fu LS, Tsai JJ, Chen YJ, Lin HK, Tsai MC, Chang MD. Heparin protects BALB\/c mice from mite-induced airway allergic inflammation. Int J Immunopathol Pharmacol. 2013;26:349\u201359.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1621_CR9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.xphs.2016.12.025","volume":"106","author":"B Patel","year":"2017","unstructured":"Patel B, Rashid J, Gupta N, Ahsan F. Low-molecular-weight heparin-coated and montelukast-filled inhalable particles: a dual-drug delivery system for combination therapy in asthma. J Pharm Sci. 2017;106:1124\u201335.","journal-title":"J Pharm Sci"},{"key":"1621_CR10","doi-asserted-by":"publisher","first-page":"e0118798","DOI":"10.1371\/journal.pone.0118798","volume":"10","author":"MD Shastri","year":"2015","unstructured":"Shastri MD, Stewart N, Eapen M, Peterson GM, Zaidi ST, Gueven N, Sohal SS, Patel RP. Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics. PLoS ONE. 2015;10:e0118798.","journal-title":"PLoS ONE"},{"key":"1621_CR11","doi-asserted-by":"publisher","first-page":"258S","DOI":"10.1378\/chest.108.4_Supplement.258S","volume":"108","author":"J Hirsh","year":"1995","unstructured":"Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995;108:258S\u201375S.","journal-title":"Chest"},{"key":"1621_CR12","doi-asserted-by":"publisher","first-page":"e0128803","DOI":"10.1371\/journal.pone.0128803","volume":"10","author":"MD Shastri","year":"2015","unstructured":"Shastri MD, Stewart N, Horne J, Zaidi ST, Sohal SS, Peterson GM, Korner H, Gueven N, Patel RP. Non-anticoagulant fractions of enoxaparin suppress inflammatory cytokine release from peripheral blood mononuclear cells of allergic asthmatic individuals. PLoS ONE. 2015;10:e0128803.","journal-title":"PLoS ONE"},{"key":"1621_CR13","first-page":"411","volume":"31","author":"PG Phillips","year":"2011","unstructured":"Phillips PG, Yalcin M, Cui H, Abdel-Nabi H, Sajjad M, Bernacki R, Veith J, Mousa SA. Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin. Anticancer Res. 2011;31:411\u20139.","journal-title":"Anticancer Res"},{"key":"1621_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10585-012-9461-9","volume":"29","author":"T Sudha","year":"2012","unstructured":"Sudha T, Phillips P, Kanaan C, Linhardt RJ, Borsig L, Mousa SA. Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model. Clin Exp Metastasis. 2012;29:431\u20139.","journal-title":"Clin Exp Metastasis"},{"key":"1621_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/1076029614565880","volume":"22","author":"A Alshaiban","year":"2016","unstructured":"Alshaiban A, Muralidharan-Chari V, Nepo A, Mousa SA. Modulation of sickle red blood cell adhesion and its associated changes in biomarkers by sulfated nonanticoagulant heparin derivative. Clin Appl Thromb Hemost. 2016;22:230\u20138.","journal-title":"Clin Appl Thromb Hemost"},{"key":"1621_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-015-0583-0","volume":"13","author":"MA Ghonim","year":"2015","unstructured":"Ghonim MA, Pyakurel K, Ibba SV, Al-Khami AA, Wang J, Rodriguez P, Rady HF, El-Bahrawy AH, Lammi MR, Mansy MS, et al. PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function. J Transl Med. 2015;13:225.","journal-title":"J Transl Med"},{"key":"1621_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jaci.2014.09.005","volume":"135","author":"MA Ghonim","year":"2015","unstructured":"Ghonim MA, Pyakurel K, Ju J, Rodriguez PC, Lammi MR, Davis C, Abughazleh MQ, Mansy MS, Naura AS, Boulares AH. DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4 T-cell function without causing severe combined immunodeficiency. J Allergy Clin Immunol. 2015;135:425\u201340.","journal-title":"J Allergy Clin Immunol"},{"key":"1621_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.molmed.2004.08.004","volume":"10","author":"TA Chatila","year":"2004","unstructured":"Chatila TA. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med. 2004;10:493\u20139.","journal-title":"Trends Mol Med"},{"key":"1621_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0083-6729(06)74007-9","volume":"74","author":"SJ Haque","year":"2006","unstructured":"Haque SJ, Sharma P. Interleukins and STAT signaling. Vitam Horm. 2006;74:165\u2013206.","journal-title":"Vitam Horm"},{"key":"1621_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","volume":"89","author":"W Zheng","year":"1997","unstructured":"Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997;89:587\u201396.","journal-title":"Cell"},{"key":"1621_CR21","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.4049\/jimmunol.0904214","volume":"185","author":"AS Naura","year":"2010","unstructured":"Naura AS, Zerfaoui M, Kim H, Abd Elmageed ZY, Rodriguez PC, Hans CP, Ju J, Errami Y, Park J, Ochoa AC, Boulares AH. Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation. J Immunol. 2010;185:3076\u201385.","journal-title":"J Immunol"},{"key":"1621_CR22","doi-asserted-by":"publisher","first-page":"1984703","DOI":"10.1155\/2016\/1984703","volume":"2016","author":"SV Ibba","year":"2016","unstructured":"Ibba SV, Ghonim MA, Pyakurel K, Lammi MR, Mishra A, Boulares AH. Potential of inducible nitric oxide synthase as a therapeutic target for allergen-induced airway hyperresponsiveness: a critical connection to nitric oxide levels and PARP activity. Mediators Inflamm. 2016;2016:1984703.","journal-title":"Mediators Inflamm"},{"key":"1621_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1183\/09031936.00057710","volume":"38","author":"H Maarsingh","year":"2011","unstructured":"Maarsingh H, Dekkers BG, Zuidhof AB, Bos IS, Menzen MH, Klein T, Flik G, Zaagsma J, Meurs H. Increased arginase activity contributes to airway remodelling in chronic allergic asthma. Eur Respir J. 2011;38:318\u201328.","journal-title":"Eur Respir J"},{"key":"1621_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2332\/allergolint.12-OA-0438","volume":"62","author":"T Ogawa","year":"2013","unstructured":"Ogawa T, Shimizu S, Shimizu T. The effect of heparin on antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats. Allergol Int. 2013;62:77\u201383.","journal-title":"Allergol Int"},{"key":"1621_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/jamp.2013.1073","volume":"27","author":"B Patel","year":"2014","unstructured":"Patel B, Gupta N, Ahsan F. Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma. J Aerosol Med Pulm Drug Deliv. 2014;27:12\u201320.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"1621_CR26","doi-asserted-by":"publisher","first-page":"e109996","DOI":"10.1371\/journal.pone.0109996","volume":"9","author":"JN Huang","year":"2014","unstructured":"Huang JN, Tsai MC, Fang SL, Chang MD, Wu YR, Tsai JJ, Fu LS, Lin HK, Chen YJ, Li TW. Low-molecular-weight heparin and unfractionated heparin decrease Th-1, 2, and 17 expressions. PLoS ONE. 2014;9:e109996.","journal-title":"PLoS ONE"},{"key":"1621_CR27","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.4049\/jimmunol.0902544","volume":"185","author":"KD Cook","year":"2010","unstructured":"Cook KD, Miller J. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol. 2010;185:3209\u201316.","journal-title":"J Immunol"},{"key":"1621_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.coph.2004.02.004","volume":"4","author":"Y Amrani","year":"2004","unstructured":"Amrani Y, Tliba O, Deshpande DA, Walseth TF, Kannan MS, Panettieri RA Jr. Bronchial hyperresponsiveness: insights into new signaling molecules. Curr Opin Pharmacol. 2004;4:230\u20134.","journal-title":"Curr Opin Pharmacol"},{"key":"1621_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ejphar.2015.03.037","volume":"759","author":"S Sagar","year":"2015","unstructured":"Sagar S, Akbarshahi H, Uller L. Translational value of animal models of asthma: challenges and promises. Eur J Pharmacol. 2015;759:272\u20137.","journal-title":"Eur J Pharmacol"},{"key":"1621_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0002-9149(64)90100-6","volume":"14","author":"JP Boyle","year":"1964","unstructured":"Boyle JP, Smart RH, Shirey JK. Heparin in the treatment of chronic obstructive bronchopulmonary disease. Am J Cardiol. 1964;14:25\u20138.","journal-title":"Am J Cardiol"},{"key":"1621_CR31","first-page":"886","volume":"98","author":"NL Fine","year":"1968","unstructured":"Fine NL, Shim C, Williams MH Jr. Objective evaluation of heparin in the treatment of asthma. Am Rev Respir Dis. 1968;98:886\u20137.","journal-title":"Am Rev Respir Dis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1621-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1621-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1621-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:01:21Z","timestamp":1589533281000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1621-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1621"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1621-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"243"}}